logo
logo

Sapphiros Acquires Flexotronix Limited

Sep 08, 2022almost 3 years ago

Acquiring Company

Sapphiros

Acquired Company

Flexotronix

BostonBiotechnologyManufacturing

Description

Sapphiros has today completed the acquisition of Flexotronix Limited. Flexotronix have developed a high speed printed electronics manufacturing line using in-house proprietary conductive inks and printed components, including batteries connectivity capability- and other diagnostic test control mechanisms. These technologies will be rapidly deployed across the Sapphiros portfolio of companies to dramatically lower consumable costs and ultimately fully automate diagnostic testing and data management for products such as the SatioDx blood draw patches and next generation Biocrucible molecular diagnostics rapid diagnostic test devices.

Company Information

Company

Sapphiros

Location

Boston, Massachusetts, United States

About

Sapphiros, backed by Neoenta and KKR, is a privately held consumer diagnostic portfolio company. The Sapphiros portfolio includes novel sample collection, next generation diagnostics, computational biology, and printed electronics to help consumers access important diagnostic results globally. Knowing Now Moves Us™ Knowledge empowers us to navigate through life’s choices and decisions. With solutions that provide real-time, definitive results; at Sapphiros we work together to help global communities act on these insights with confidence.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed